Keywords: BioSante, Female libido, LibiGel, Testosterone gel

BioSante female libido drug flops in Ph III studies

Article | 16 December 2011

Print This

US biotechnology firm BioSante Pharmaceuticals (Nasdaq: BPAX) saw its shares go into free fall in extended trading, after the company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in